Cefotaxime (Mayne Pharma)

What it is used for

INDICATIONS: Cefotaxime is indicated for the treatment of the following types of infection when caused by susceptible micro-organisms: Infections of the respiratory tract (upper and lower). Infections of the urinary tract. Septicaemia – concomitant therapy with an aminoglycoside may be instituted prior to isolation of the causative organism. Intra-abdominal infection. Gonorrhoea (including gonorrhoea caused by beta lactamase producing strains of N.gonorrhoeae). Ear, nose and throat infections. Skin and skin structure infections. Bone and joint infections. Meningitis – cefotaxime should be combined with an appropriate alternative antibiotic (ampicillin, chloramphenicol or penicillin G) for initial therapy in children, (excluding neonates) pending the availabiliy of culture and sensitivity results. In adults, the empirical use of cefotaxime should be restricted to patients suspected of having meningitis caused by Gram negative enteric bacilli. Cefotaxime may be used for the prevention of post-operative infection in obstetrical surgery, vaginal and abdominal hysterectomy and biliary surgery. In serious cases, cefotaxime may be used, if considered appropriate,before the results of sensitivity tests become available. The emergency of resistance to cefotaxime may complicate treatment.